MedPath
HSA Approval

APO-FUROSEMIDE TABLET 40 mg

SIN00088P

APO-FUROSEMIDE TABLET 40 mg

APO-FUROSEMIDE TABLET 40 mg

March 14, 1988

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C03CA01

furosemide

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

FRUSEMIDE

40 mg

Furosemide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-FUROSEMIDE TABLET 40 mg - HSA Approval | MedPath